Signal 1, founded in 2022 and headquartered in Toronto, Canada, operates at the intersection of artificial intelligence and healthcare delivery. The company builds technology for hospitals and health systems across North America, focusing on translating AI innovation into measurable clinical, operational, and financial outcomes within real healthcare environments.
The firm's principal offering is its AI Management Platform (AIMS), an end-to-end system designed to give health systems comprehensive oversight across predictive, generative, and agentic AI applications. AIMS introduces governance workflows and guardrails intended to help organisations accelerate AI adoption while mitigating the downside risks inherent in deploying advanced models in clinical settings. Complementing this, Signal 1 developed CHARTWatch, a real-time patient risk predictor that forecasts which hospital patients are likely to deteriorate, enabling earlier interventions.
Signal 1's technical work spans several domains, including health AI, patient risk prediction, predictive AI, generative AI, and agentic AI. The company positions itself as setting the standard for responsible AI deployment in healthcare, with a stated mission to transform patient care through technology that is governed, monitored, and built with clinical accountability in mind.
